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Abstract 
Aims Nicotine is known to enhance aspects of cognitive functioning in abstinent 
smokers but the effects on specific areas of executive functions, and in non-smokers 
are inconclusive. This may be due in part to the poor sensitivity of tests used to assess 
executive functions. This study used a new virtual reality assessment of executive 
functions known as JEF (the Jansari assessment of Executive Functions) to address 
this issue.  
Design 2x2 design manipulating group (smokers and never-smokers) and drug 
(nicotine [4mg for smokers; 2mg for never smokers] vs placebo gum).  
Setting School of Psychology; University of East London 
Participants 72 participants (aged 18 to 54).  36 minimally-deprived (2 hr) smokers 
and 36 never-smokers. 
Measurements Components of executive function were measured using the virtual 
reality paradigm JEF, which assesses eight cognitive constructs simultaneously as 
well as providing an overall performance measure.  
Results  Univariate ANOVAs revealed that nicotine improved overall JEF 
performance, time-based prospective memory and event-based prospective memory 
in smokers (p < 0.01) but not in never-smokers.  Action-based prospective memory 
was enhanced in both groups (p < 0.01) and never-smokers out-performed smokers 
on selective thinking and adaptive thinking (p < 0.01). 
Conclusions. Overall executive functioning and prospective memory can be 
enhanced by nicotine gum in abstinent smokers. That smokers were only minimally 
deprived suggests that JEF is a sensitive measure of executive functioning and that 
prospective memory is particularly susceptible to disruption by abstinence. 
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Introduction 
Nicotine is thought to play a significant role in the maintenance of smoking 
behaviour through its effect on psychological functions (1). Nicotine is a cholinergic 
agonist, which mimics the action of acetylcholine, a neurotransmitter associated with 
effortful cognitive processes (2). Nicotine also acts on the mesolimbic dopaminergic 
reward system (3), which is associated with both increased pleasure and reduction of 
negative affect (4,5). Individuals may smoke to obtain certain effects (e.g. pleasure, 
stimulation) or remove unwanted effects (e.g. negative affect, tiredness). In addition 
to its effects on mood nicotine’s effect on cognition may also contribute to smoking 
addiction. In nicotine-dependent smokers, nicotine abstinence results in pronounced 
cognitive impairments (6,7), and this effect has been observed as early as 30 minutes 
post cigarette (8). These impairments are typically reversed following the smoking of 
one or two cigarettes (6).  
 
Although it is widely agreed that nicotine withdrawal leads to cognitive decrements, 
there is less agreement over the precise effects of nicotine on cognition. Smokers 
often report that smoking aids them in memory and concentration (9). If nicotine does 
have an absolute facilitative effect on cognition this might to some extent explain 
why individuals initiate the habit. In addition, this enhancement effect might also 
represent another potential form of smoking reinforcement. Subjective reports, 
although interesting, cannot provide objective evidence as to whether or not smoking 
enhances cognitive performance in addition to reversing withdrawal deficits.  
Nicotine has been shown to improve sustained attention in non-deprived smokers and 
non-smokers (11,12). However, findings relating to the impact of nicotine on 
working memory (WM) have been less consistent. Nicotine’s effect on WM has 
included enhancement (13), impairment (14), or no effects (15).  
Myers, Taylor, Moolchan and Heishman (12) found no effects of nicotine nasal spray 
on WM performance in deprived and non-deprived smokers. Kleykamp et al, (14) 
attempted to determine the effects of nicotine on working memory, attention and 
executive function using the n-back task and the Attention Network Task (ANT) that 
assesses alerting, orienting, and executive function aspects of attention. They found 
no effects of nicotine on their cognitive measures in never smokers in a within 
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participant design using 0mg, 2mg and 4mg nicotine gum (although there was a dose 
related effect of nicotine on heart rate)(14).  
 
A review carried out by Heishman, Kleykamp and Singleton (6) examined the effect 
of nicotine on various aspects of cognitive performance in 41 double-blind placebo 
controlled studies between 1994 and 2008 in non smokers and smokers not 
experiencing withdrawal. Meta-analyses revealed significant positive effects of 
nicotine on fine motor abilities, overall accuracy and response times for alerting and 
orienting attention consistent with their earlier review. Meta-analyses also confirmed 
significant effects of nicotine on working memory RT and accuracy of episodic 
memory performance; findings that, the authors suggest, capture true performance 
facilitation effects rather than withdrawal relief and reflect the use of more 
sophisticated cognitive measures. The authors conclude that these findings provide 
indirect evidence that nicotine’s performance enhancing effects may indeed 
contribute to the initiation of smoking (6) in contrast to their earlier conclusions that 
nicotine was unlikely to be a contributing factor in starting smoking (6).  
In relation to executive functions specifically, to date there have been few published 
reports on the effects of nicotine.  In the Heishman et al. (6) review it was not 
possible to determine the effect of nicotine on executive function and complex 
cognition as there were insufficient effect sizes to conduct a meta-analysis. The 
authors also noted that there were no studies that met the inclusion criteria that 
investigated learning or executive functions, such as decision-making and planning 
and that there were no studies that related laboratory tasks to real-world performance. 
 
In verbal fluency tasks, thought to tap executive aspects of retrieval strategies, 
inhibitory functioning and memory monitoring, nicotine has been shown to both 
improve (16) and have no effect on performance in smoking groups (17). In non-
smokers, however, nicotine has been shown to have no effect on task performance 
(18). On the basis of an attention scale measurement Poltavski and Petros (19) split 
male non-smokers into two groups, high and low attentiveness. Nicotine 
administration in the high attentiveness group led to poorer performance on the 
Wisconsin Card Sort Test (20). This finding suggests that in areas assessed by the 
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WCST such as strategic planning, set shifting and mental flexibility (21, 22) nicotine 
may in fact impair rather than enhance performance.  
 
Prospective Memory, or the forming of a delayed intention (23, 24) is thought to 
incorporate strategic processing in areas of intention formation and intention 
execution. In a number of recent studies nicotine has been shown to improve 
prospective memory performance in minimally deprived (2 h) smokers (25, 26) and 
non-smokers (25). These findings suggest that nicotine can significantly improve 
performance when task conditions engage strategic and effortful processing and 
stretch cognitive resources In Heishman et al.’s review (6) it was not possible to 
determine the effect of nicotine on long-term prospective memory, as there was an 
insufficient effect size to conduct a meta-analysis. Recent studies have also pointed to 
nicotine enhancing inhibitory processes in memory (27, 28).  
 
In a recent review Evans and Drobes (29) pointed to evidence suggesting that the 
absolute effects of nicotine on cognition might only become apparent in 
environmentally complex real-life activities. In a study of non-smoking pilots 
nicotine was shown to improve performance in complex flight simulation tasks in 
comparison to placebo (30). Multiple aspects of cognition are involved in complex 
flight performance, including attention and memory, and involve high cognitive 
loads. Unfortunately Mumenthaler et al. (30) were unable to provide a way of 
measuring the effects of nicotine on the various different cognitive domains involved.  
 
To address the fact that traditional assessments of cognitive performance lack 
ecological validity and sensitivity, Jansari, Agnew, Akesson, & Murphy (31) have 
developed a virtual reality assessment known as JEF (Jansari assessment of 
Executive Functions1
                                                 
1 In previous papers, the JEF was known by a different acronym JAAM; however, 
). JEF examines a range of executive functions concurrently, 
namely planning, prioritization, selection, creative-thinking, adaptive thinking, time-
based prospective memory, event-based prospective memory and action-based 
prospective memory. Performance is assessed independently for each cognitive 
construct and in addition an average performance score across all constructs is also 
the assessment is unchanged between the different studies 
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provided; this provides the researcher with an overall understanding of the 
participant’s level of executive functions as well as a breakdown of performance on 
individual elements. JEF was originally developed to assess executive functions in a 
sample of brain injured participants showing significantly lower performance than 
age and IQ-matched healthy controls (31), but importantly has also been used in non 
brain-damaged populations to explore the impact of ecstasy (32), alcohol (33) and 
cannabis (34). 
 
In summary, findings on the absolute facilitative effects of nicotine on cognitive 
performance are inconsistent and present a complex picture displaying 
improvements, null effects and decrements in abstinent and non-deprived smokers as 
well as non-smokers. The use of JEF responds directly to the gap in the literature 
with specified cognitive constructs that can capture isolated elements of executive 
functioning that reflect theories of fractionated executive processes (35). This study 
compares the effects of nicotine on abstinent smokers and non-smokers using a 
sensitive ecologically-valid measure of executive functions.  
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Method 
Design  
A between participants design was used with smoking group (smoker versus never-
smoker) and gum type (nicotine versus placebo) as the independent variables.  The 
dependent variables were scores on the various JEF constructs. 
 
Participants  
72 participants were recruited, 36 (21 female) smokers and 36 never-smokers (18 
female), a sample size that is comparable to other studies exploring the effects of 
nicotine on cognition in smokers and non-smokers (6, 25).  Participants were 
recruited via Internet advertising (Gumtree) and university e-mailing (70% were 
students). Never-smokers had smoked fewer than 20 cigarettes in their lifetime while 
smokers smoked at least 10 cigarettes a day and smoked their first cigarette within 
one hour of waking. The University of East London Ethics Committee approved the 
research.  
 
 
Preparation of nicotine and placebo gums  
2mg and 4mg Nicorette freshmint nicotine gums were used respectively for never-
smokers and smokers along with Wrigleys Extra peppermint regular chewing gums. 
The gums were wrapped in an extra piece of regular chewing gum to hide their 
appearances, and two drops of Tabasco pepper sauce were used to hide the nicotine 
taste. This has been used effectively in previous research (37). 
 
Tasks 
JEF (31) is a virtual reality assessment that involves the participant playing the role 
of an office assistant. Participants read the scenario, which describes their role and 
they are shown how to navigate around the environment after being given time to 
practice using the assessment. The participant is given a list of tasks to complete for 
the office manager who they are informed is out of the building for the day. In 
addition to these tasks the participant is also handed a number of memos during the 
assessment relating to additional tasks or events. In this respect, the tasks reflect 
those that would naturally occur in a typical working environment, and rely on 
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working memory and task switching. Executive Function is assessed through eight 
cognitive constructs: Planning, Prioritisation, Selection, Creative Thinking, Adaptive 
Thinking and three types of Prospective Memory (Action-Based, Event-Based and 
Time-Based). Participants are required to carry out two tasks for each construct and 
their performance on each task is assessed through predetermined criteria and a 
corresponding three-level scoring system. Participants receive a score of 0, 1 or 2 for 
each task depending on how successful they are at meeting the requirements of the 
task criteria. As an example, for the Planning construct the participant is required to 
group the manager’s list of tasks in a practical and sensible manner and to also 
arrange the tables and chairs for the members of the meeting. Scoring was conducted 
on the full completed set of anonymised (numerically coded) data by the test 
administrator.   Performance is scored manually against a strict protocol on a 
proforma for which previous studies have demonstrated an inter-rater reliability 
ranging between 0.956 and 1.0 for scoring on individual constructs.  
 
In total, the JEF task takes approximately 40 minutes to complete. The scores for the 
tasks are then summed and a percentage score calculated for each construct. An 
overall performance score is calculated as the mean average of the eight construct 
percentage scores.   
 
Procedure  
Smokers were asked to abstain from smoking for two hours prior to testing consistent 
with Rusted & Trawley (25). The assessment was administered in a quiet laboratory 
in isolation. Smokers and never-smokers were randomly allocated to a nicotine or 
placebo group according to the order in which they were recruited to the study (quasi-
randomization approach). Smokers in the nicotine group were given 4mg nicotine 
gum. Never-smokers in the nicotine group were given a 2mg gum, because higher 
doses of nicotine have been shown to have adverse effects on non-smokers (38). 
Participants were asked to follow the Nicorette manufacturer’s instructions (Nicorette 
ActiveStop Freshmint 2mg and 4mg gum) when chewing the nicorette and placebo 
gums. Participants chewed the gum until the taste became strong, rested it between 
the gum and cheek for several minutes, and then chewed the gum again for several 
minutes. Participants repeated this chewing procedure for 20 minutes before testing 
to allow for maximum blood sera levels of nicotine to be attained through the buccal 
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mucosa (39). Studies that used similar placebo preparation and chewing procedures 
reported that compared with a placebo condition, the 2mg gum can increase plasma 
nicotine levels by approximately 4.6 ng/mL, and the 4mg gum can increase plasma 
nicotine levels by approximately 8.5 ng/mL (40). A cigarette, by way of comparison, 
can increase plasma nicotine levels by approximately 14 ng/mL (41). During the 20-
minute chewing period participants completed the WTAR IQ Test. Participants then 
carried out the JEF assessment and removed the gum upon completion of the 
assessment.  Participants were reminded of their right to withdraw at anytime 
throughout the testing session.  Never-smokers tolerated the gum very well with only 
a handful reporting any side effects (mild nausea/light-headedness) and none 
withdrawing or having to be excluded.   
 
 
Results 
As can be seen from Table 1, groups were well matched in terms of age and IQ. 
 
 Never-smoker 
Nicotine 
N = 18 
Never-smoker 
Placebo 
N = 18 
Smoker 
Nicotine 
N = 18 
 
Smoker 
Placebo 
N = 18 
F 
(3,68) 
 
p 
Age 27.94 (7.76) 28.94 (11.50) 24.88 (4.12) 27.73 (8.27) 0.79 0.50 
IQ 112.5 (6.86) 112.7 (8.43) 112.3 (9.56) 111.2 (9.09) 0.11 0.96 
 
Table 1 
Participant Demographics showing mean Age and IQ as a function of group (standard deviations in 
parentheses)  
 
 
 
Planning, selective thinking, creating thinking, adaptive thinking, time-based PM and 
event-based PM were negatively skewed.  Levene’s test was significant (< 0.02)  for 
creative thinking, selective thinking, time-based PM, event-based PM and overall 
total, reflecting, in each case, larger variance in the smoker/placebo group.  To reduce 
negative skewing, the offending variables were reflected and square root transformed 
before being subjected to univariate analyses of variance (ANOVA).  This reduced 
the skewing but did not correct the violation of homogeneity thus a more stringent α 
level of 0.01 was adopted to minimize the risk of Type I errors.  The group x gum 
type interaction is of primary interest here, this was therefore tested first in each case; 
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where significant interactions were observed, post-hoc t-tests were conducted for 
smokers and never-smokers to clarify the nature of the interaction.  Main effects are 
only reported in the absence of a significant interaction in a model that excludes the 
interaction term.     
 
 
Figure 1 shows JEF performance scores across the eight individual cognitive 
constructs and overall average performance as a function of smoking group (smoker 
vs never-smoker) and gum type (nicotine vs placebo). Exact figures (group means 
and SDs) are also provided in Table 2.  For overall total JEF score, there was a 
significant smoking group x gum type interaction. Post-hoc t-tests confirmed that the 
superior performance in the nicotine versus placebo group was statistically significant 
in smokers (t(34) = 4.4, p< .0001) but fell short of the adjusted level of significance 
in never-smokers (t(34) = 2.12, p=.04). 
 
 
 
 
Figure 1:  
 JEF performance scores as a function of group and cognitive construct (error bars represent one 
standard error). NS-N = Non-smoker Nicotine, NS-P = Non-smoker Placebo, S-N = Smoker Nicotine, 
S-P = Smoker Placebo 
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 Never-
smoker 
Nicotine 
Never-
smoker 
Placebo 
Smoker 
Nicotine 
Smoker 
Placebo 
F, p 
Inter-
action 
(df=3,68) 
F, p 
Group  
Main 
(df=1,69) 
F, p 
Gum 
Main 
(df=1,69) 
Planning 89.82 
(17.27) 
 
84.26 
(16.63) 
85.18 
(22.06) 
73.15 
(25.65) 
0.44, 
0.51 
1.87, 
0.18 
4.27 
0.04 
Prioritisation 80.56 
(18.30) 
 
81.94 
(11.52) 
76.39 
(20.06) 
65.22 
(22.89) 
2.03, 
0.16 
5.64, 
0.02 
1.24, 
0.27 
Selective 
Thinking 
94.44 
(10.69) 
91.67 
(12.13) 
80.56 
(26.51) 
79.17 
(24.63) 
0.02, 
0.88 
6.77, 
0.01 
0.28, 
0.60 
 
Creative 
Thinking 
77.78 
(24.08) 
83.33 
(22.69) 
70.83 
(31.21) 
61.06 
(40.40) 
1.14, 
0.29 
3.39, 
0.07 
0.01, 
0.93 
 
Adaptive 
Thinking 
86.11 
(19.60) 
77.78 
(24.08) 
66.67 
(33.21) 
56.94 
(25.45) 
0.01, 
0.91 
10.27, 
0.002 
2.48, 
0.12 
 
Action-based 
PM 
76.39 
(24.96) 
56.94 
(26.85) 
66.67 
(38.35) 
37.50 
(31.21) 
0.45, 
0.51 
4.04, 
0.05 
11.23, 
0.001 
 
Event-based 
PM 
97.22 
(11.79) 
94.44 
(13.71) 
94.44 
(13.71) 
51.39 
(35.84) 
12.94, 
0.001 
 
- - 
Time-based 
PM 
94.44 
(10.69) 
88.89 
(17.62) 
94.44 
(13.71) 
61.11 
(33.46) 
6.34, 
0.01 
- - 
Overall 
Average 
87.27  
(6.94) 
82.42  
(6.82) 
79.41 
(12.94) 
60.60 
(12.72) 
8.28, 
0.005 
- - 
Table 2:   
Mean (SD) JEF performance scores as a function of group and cognitive construct.  Main effects are 
only reported in the absence of a significant interaction (α = 0.01).    
 
 
 
In relation to the individual cognitive constructs, as can be seen from Table 2, 
ANOVA revealed a significant interaction for event-based and time-based 
prospective memory.  Follow up post-hoc t-tests confirmed significantly better 
performance in the nicotine versus placebo group for event-based and time-based 
12 
 
prospective memory in smokers (t(26.06) = -4.68, p <.001 and t(26.46) = -3.91, 
p=.001 respectively) but not in never-smokers (t(34) = -.82, p=.42 and t(31.20) = -
.98, p=.34 respectively). 
 
 
 
In the absence of significant interactions for the remaining cognitive constructs, main 
effects were explored.  As can be seen from Table 2, never-smokers out-performed 
smokers across all cognitive constructs with statistically significant group differences 
emerging for selective and adaptive thinking.  The only main effect of gum type that 
emerged in the absence of an interaction was for action-based prospective memory 
with superior performance under nicotine.   
 
 
 
Discussion 
The aim of this study was to explore the effects of nicotine in smokers and never-
smokers on specific aspects of executive functions using the JEF.  Never-smokers 
out-performed smokers on selective and adaptive thinking and participants receiving 
nicotine performed better on action-based prospective memory. Significant 
interactions between smoking group and gum type for overall JEF performance and 
event-based and time-based prospective memory reflected enhanced performance by 
nicotine in smokers but not in never-smokers; this is clearly visible in Figure 1 and 
Table 2 and is consistent with pre-existing research which demonstrates that nicotine 
abstinence in regular smokers results in cognitive-attentional deficits which can be 
reversed with acute nicotine administration (11). 
 
Inspection of the individual executive constructs assessed here by JEF, suggest that 
prospective memory is particularly susceptible to abstinence-associated disruption 
and subsequent improvement with acute nicotine administration. In fact, nicotine was 
observed to improve performance in this group in all three categories of prospective 
memory; Action-based Prospective Memory, Event-based Prospective Memory and 
Time-based Prospective Memory. These results are consistent with previous findings 
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showing that nicotine improves memory performance when task conditions stretch 
cognitive resources, involve effortful processing or require strategic processing of the 
to-be-remembered material (6, 42, 43, 13, 26). Unlike Rusted and Trawley (25) 
however, in the present study, with the exception of action-based prospective 
memory, nicotine did not improve performance in never-smokers. These 
discrepancies might reflect differences in the type of prospective memory task used 
and/or dose and mode of nicotine administration (2mg gum for never smokers here 
vs. 1mg nasal spray). 
 
According to the multi-process theory of prospective memory, time-based tasks rely 
more heavily on strategic processes dependent on prefrontal systems than event-
based tasks. Einstein and McDaniels (23) argue that there is a need to self-initiate 
retrieval of an intention in time-based tasks. In event-based tasks the introduction of 
external cues in the initiation phase of prospective memory means that there is less 
reliance on strategic processes. In the current study nicotine improved both time-
based and event-based tasks and both results came with comparable small effect sizes 
(partial η² of 0.188 and partial η² of 0.236 respectively). These results are not 
consistent with Einstein and McDaniel’s (23) theory where we would expect a greater 
effect on time-based prospective memory. The pronounced effect of nicotine on all 
three areas of prospective memory may be because the prospective memory tasks are 
competing with other distinct ongoing tasks in JEF.  
 
More recent formulations of memory processes have underlined the role of inhibitory 
mechanisms in the processing of efficient remembering (44, 45, 46). That is, the 
suppression of irrelevant material is key in the effective processing of relevant 
material. Indeed, there is a growing body of evidence suggesting that nicotine can 
improve inhibitory control; using the retrieval-induced forgetting paradigm, Edginton 
and Rusted (27) and Rusted and Alvares (28) have reported positive effects of 
nicotine on the ability to inhibit task-irrelevant semantic information. Similarly, 
Powell, Dawkins and Davies (17) and Dawkins et al. (47) have observed a nicotine-
induced enhancement of antisaccade performance in abstinent smokers.    
 
In the JEF paradigm participants are required to remember a number of intentions 
and are then to retrieve the correct intention at a specific time or in response to the 
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associated cue. To our knowledge this has not been explored within the domain of 
prospective memory, but it is possible that nicotine serves to improve the retrieval of 
the relevant intention by suppressing other irrelevant intentions. An example of this 
can be seen in the JEF paradigm; the participant is asked to turn on the coffee 
machine when the first person arrives for the meeting (event-based prospective 
memory task), and to turn on the projector 10 minutes before the meeting begins 
(time-based prospective memory task). When each cue occurs during the assessment 
the participant is faced with a number of competing and related intentions. It is 
possible that in order to retrieve the relevant intention the participant must suppress 
the irrelevant intentions and that nicotine serves to enhance this process.    
 
In this study nicotine did not affect performance in any of the five remaining 
constructs of executive functions: Planning, Prioritisation, Selection, Creative 
Thinking, and Adaptive Thinking.  This is consistent with other studies, which have 
shown that nicotine has a differential effect on specific aspects of cognitive 
performance (18, 19, 42). These findings further suggest that the memory processes 
involved in prospective memory are particularly vulnerable to short periods of 
smoking deprivation and improvement with acute nicotine administration. It is 
possible however, that a longer period of smoking abstinence than used here (2 
hours) may reveal significant effects in some of these other areas of cognition.   
 
Due to the perennial problem of administering high dose nicotine to never-smokers, 
the present study used 4mg nicotine gum for smokers and 2mg for non-smokers, a 
protocol which has been used successfully elsewhere (37).  It is possible that the 
larger effects sizes observed in smokers here may reflect this difference in dosage.  
Inspection of Figure 1, however reveals poorer performance in abstinent smokers 
(those receiving placebo) across all constructs but on no occasion did smokers 
receiving nicotine (4mg) out-perform never-smokers receiving nicotine (2mg) 
suggesting that the observed effects are driven by a restorative effect of nicotine in 
abstinent smokers rather than a dose effect. 
 
Finally, main effects of smoking group were observed in the absence of an interaction 
for selective thinking and adaptive thinking with never-smokers out-performing 
smokers.  Trends for better performance in never-smokers (which fell short of the 
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adjusted level of significance) were also seen for prioritisation and action-based 
prospective memory.  Given the well-matched IQs across smoking groups, this 
pattern of findings is consistent, although not exclusively, with previous research 
showing that chronic smoking is associated with cerebral degeneration or brain 
atrophy (48, 49) and impaired executive functioning, cognitive flexibility, working 
memory and prospective memory (50, 51).   
 
To conclude, the current findings support a restorative effect of acute nicotine in 
reversing abstinence-induced executive functioning impairments in smokers. 
Abstinence-induced impairments and improvement by nicotine were most apparent in 
all three domains of prospective memory possibly as a result of nicotinic stimulation 
on inhibitory control.  That impairments were observed in smokers here after only 2 
hours of abstinence suggests that prospective memory as assessed by JEF is 
particularly sensitive to nicotine deprivation.  Whether such deficits are a 
consequence or cause of regular smoking remains to be determined.   
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